Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)May 31, 2025 | (FY)May 31, 2024 | (FY)May 31, 2023 | (FY)May 31, 2022 | (FY)May 31, 2021 | (FY)May 31, 2020 | (FY)May 31, 2019 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||||
| Cash from operating activities | -52.25%337.13M | 91.86%706.01M | -38.98%367.97M | 17.26%603M | 330.75%514.22M | -68.08%119.38M | 373.95M |
| Net profit before non-cash adjustment | -25.30%350.05M | 33.54%468.59M | -17.55%350.9M | 113.21%425.6M | 1,776.27%199.62M | 119.01%10.64M | ---55.97M |
| Total adjustment of non-cash items | 127.78%256.37M | -22.05%112.55M | 21.57%144.39M | -58.84%118.78M | -49.65%288.59M | 27.22%573.14M | --450.53M |
| -Depreciation and amortization | 18.77%161.75M | 11.39%136.19M | 20.77%122.26M | -18.57%101.23M | -43.05%124.32M | -19.30%218.3M | --270.51M |
| -Reversal of impairment losses recognized in profit and loss | --79.76M | --0 | ---- | ---- | -53.94%136.63M | 116.25%296.63M | --137.17M |
| -Disposal profit | 103.81%287K | -83,555.56%-7.53M | 99.65%-9K | -295.65%-2.56M | -95.46%1.31M | 158.38%28.87M | --11.17M |
| -Net exchange gains and losses | -290.06%-8.98M | 52.55%-2.3M | ---4.85M | --0 | ---- | ---- | ---- |
| -Remuneration paid in stock | 9.85%6.94M | -42.12%6.31M | 177.13%10.91M | --3.94M | ---- | ---- | ---- |
| -Other non-cash items | 182.64%16.62M | -225.08%-20.12M | -0.53%16.08M | -38.57%16.17M | -10.29%26.32M | -7.37%29.34M | --31.67M |
| Changes in working capital | -315.65%-269.29M | 198.08%124.87M | -317.21%-127.32M | 125.26%58.62M | 105.60%26.02M | -2,153.17%-464.4M | ---20.61M |
| -Change in receivables | -19.49%178.43M | 1,757.48%221.64M | 113.97%11.93M | -142.16%-85.42M | 144.48%202.62M | -431.45%-455.56M | ---85.72M |
| -Change in inventory | -325.94%-183.53M | 183.71%81.23M | -330.15%-97.03M | 81.43%-22.56M | -9.27%-121.46M | -146.80%-111.16M | ---45.04M |
| -Change in payables | 45.84%-161.95M | -3,584.19%-299.01M | -96.83%8.58M | 2,747.82%271M | 174.36%9.52M | 81.12%-12.8M | ---67.78M |
| -Provision for loans, leases and other losses | -114.84%-4.38M | 157.36%29.53M | 41.85%-51.48M | -471.82%-88.52M | 1.40%23.81M | -55.26%23.48M | --52.48M |
| -Changes in other current assets | -1,255.49%-106.47M | -374.62%-7.86M | 94.14%-1.66M | -313.62%-28.24M | 98.83%13.22M | -86.15%6.65M | --48.02M |
| -Changes in other current liabilities | -91.32%8.62M | 4,160.16%99.35M | -81.13%2.33M | 112.15%12.36M | -219.65%-101.68M | 9.75%84.98M | --77.43M |
| Dividends paid (cash flow from operating activities) | |||||||
| Dividends received (cash flow from operating activities) | |||||||
| Interest paid (cash flow from operating activities) | -54.36%-29.63M | -8.85%-19.19M | -4.93%-17.63M | 37.72%-16.81M | 15.90%-26.98M | 2.61%-32.08M | -32.94M |
| Interest received (cash flow from operating activities) | 120.15%12.39M | 250.28%5.63M | 0.94%1.61M | 17.32%1.59M | 2.42%1.36M | -2.93%1.33M | 1.37M |
| Tax refund paid | -89.87%-103.94M | -57.49%-54.74M | 44.72%-34.76M | -6,668.25%-62.88M | -410.70%-929K | 208.33%299K | -276K |
| Other operating cash inflow (outflow) | 0.00%-1K | -1K | 0 | 0 | 0.00%-1K | -200.00%-1K | 1K |
| Operating cash flow | -66.13%215.96M | 101.05%637.7M | -39.57%317.19M | 7.64%524.91M | 448.44%487.67M | -74.01%88.92M | --342.1M |
| Investing cash flow | |||||||
| Net PPE purchase and sale | -50.20%-327.79M | -265.17%-218.24M | 57.96%-59.76M | -190.45%-142.16M | -166.80%-48.95M | 120.27%73.27M | ---361.38M |
| Net intangibles purchase and sale | 45.87%-7.4M | 72.91%-13.68M | -108.47%-50.5M | -255.78%-24.23M | ---6.81M | ---- | --50K |
| Net investment product transactions | -445.26%-36.42M | 121.18%10.55M | -542.02%-49.8M | -145.44%-7.76M | -60.57%-3.16M | -103.86%-1.97M | --51.02M |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | 86.05%-270K | ---1.94M |
| Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | 44.28%1.38M | --953K |
| Net changes in other investments | 110.21%1.11M | -362.72%-10.86M | -9.72%-2.35M | -281.27%-2.14M | -98.16%1.18M | 3,214,550.00%64.29M | --2K |
| Investing cash flow | -59.54%-370.5M | -42.99%-232.23M | 7.87%-162.41M | -205.33%-176.28M | -142.24%-57.73M | 143.91%136.7M | ---311.29M |
| Financing cash flow | |||||||
| Net issuance payments of debt | 255.87%211.54M | -15.53%-135.72M | 66.67%-117.48M | 70.76%-352.48M | -455,025.28%-1.21B | 101.29%265K | ---20.59M |
| Net common stock issuance | -67.74%713K | -86.64%2.21M | 122.10%16.54M | -108.34%-74.86M | 1,955.18%898.11M | --43.7M | ---- |
| Increase or decrease of lease financing | 7.16%-1.82M | -133.41%-1.96M | 42.29%-838K | 8.56%-1.45M | -195.72%-1.59M | 33.13%-537K | ---803K |
| Cash dividends paid | -17.12%-87.24M | -5.48%-74.49M | -28.75%-70.62M | -3,593.27%-54.85M | -23.75%-1.49M | 0.00%-1.2M | ---1.2M |
| Net other fund-raising expenses | ---1K | ---- | ---- | --1K | ---- | ---1K | ---- |
| Financing cash flow | 158.68%123.2M | -21.79%-209.95M | 64.36%-172.39M | -55.75%-483.64M | -835.34%-310.51M | 286.93%42.23M | ---22.59M |
| Net cash flow | |||||||
| Beginning cash position | 23.20%1.05B | -1.47%852.61M | -13.50%865.36M | 13.56%1B | 43.49%880.95M | 1.25%613.96M | --606.4M |
| Current changes in cash | -116.03%-31.34M | 1,210.32%195.52M | 86.96%-17.61M | -213.05%-135.01M | -55.41%119.42M | 3,161.62%267.84M | --8.21M |
| Effect of exchange rate changes | 290.06%8.98M | -52.55%2.3M | --4.85M | --0 | ---- | -30.38%-854K | ---655K |
| Cash adjustments other than cash changes | 0.00%1K | --1K | ---- | ---2K | ---- | 200.00%2K | ---2K |
| End cash Position | -2.13%1.03B | 23.20%1.05B | -1.47%852.61M | -13.50%865.36M | 13.56%1B | 43.49%880.95M | --613.96M |
| Free cash flow | -130.18%-120.26M | 92.61%398.53M | -41.64%206.91M | -17.89%354.57M | 6,045.15%431.82M | 135.41%7.03M | ---19.84M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | Unqualified Opinion | -- | -- |